Literature DB >> 21071977

Tuberous sclerosis complex renal disease.

Bradley P Dixon1, John C Hulbert, John J Bissler.   

Abstract

Although not as common as other genetic renal diseases such as autosomal dominant polycystic kidney disease, patients with tuberous sclerosis complex frequently have significant renal involvement. Recent revelations in the cell biology of these renal disease manifestations as well as effective therapies for tuberous sclerosis complex-related renal issues have heralded hope of improved renal survival and improved quality of life for the TSC patient. This review specifically addresses some of the major renal manifestations of this disease.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21071977      PMCID： PMC2992644          DOI： 10.1159/000320891

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN： 1660-2129


  44 in total

1.  Angiolipo-leiomyoma of the kidney; report of a case with observations on histogenesis.

Authors:  D N TWEEDDALE; C J DAWE; J R McDONALD; O S CULP
Journal:  Cancer       Date:  1955 Jul-Aug       Impact factor: 6.860

2.  Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations.

Authors:  Jason Hafron; James D Fogarty; David M Hoenig; Maomi Li; Robert Berkenblit; Reza Ghavamian
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

3.  The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas.

Authors:  Gary M Israel; Nicole Hindman; Elizabeth Hecht; Glenn Krinsky
Journal:  AJR Am J Roentgenol       Date:  2005-06       Impact factor: 3.959

4.  Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.

Authors:  J R Sampson; M M Maheshwar; R Aspinwall; P Thompson; J P Cheadle; D Ravine; S Roy; E Haan; J Bernstein; P C Harris
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Angiomyolipoma: imaging findings in lesions with minimal fat.

Authors:  M Jinzaki; A Tanimoto; Y Narimatsu; K Ohkuma; T Kurata; H Shinmoto; K Hiramatsu; M Mukai; M Murai
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

6.  Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma.

Authors:  M Pea; F Bonetti; G Martignoni; E P Henske; E Manfrin; C Colato; J Bernstein
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

Review 7.  Angiomyolipoma of kidney.

Authors:  J N Eble
Journal:  Semin Diagn Pathol       Date:  1998-02       Impact factor: 3.464

8.  Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma.

Authors:  U Patel; E Simpson; J C Kingswood; A K Saggar-Malik
Journal:  Clin Radiol       Date:  2005-06       Impact factor: 2.350

9.  Renal lesion growth in children with tuberous sclerosis complex.

Authors:  D H Ewalt; E Sheffield; S P Sparagana; M R Delgado; E S Roach
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

10.  Management of renal angiomyolipoma: analysis of 15 cases.

Authors:  O J Kessler; G Gillon; M Neuman; D Engelstein; H Winkler; J Baniel
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096
View more
  42 in total

1.  Unexpected diagnosis in a child with hemolytic uremic syndrome: Answers.

Authors:  Eimear Kirby; Shiraz Elbashier; Clodagh Sweeney; Eilish Twomey; Kathleen Gorman; Michael Riordan; Atif Awan
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.714

Review 2.  New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.

Authors:  Hilaire C Lam; Julie Nijmeh; Elizabeth P Henske
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

Review 3.  The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.

Authors:  Paolo Curatolo; Marit Bjørnvold; Patricia E Dill; José Carlos Ferreira; Martha Feucht; Christoph Hertzberg; Anna Jansen; Sergiusz Jóźwiak; J Christopher Kingswood; Katarzyna Kotulska; Alfons Macaya; Romina Moavero; Rima Nabbout; Bernard A Zonnenberg
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

4.  Commentary.

Authors:  Leonardo Oliveira Reis; Emerson Luís Zani
Journal:  Urol Ann       Date:  2012-05

Review 5.  Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.

Authors:  S Brakemeier; F Bachmann; K Budde
Journal:  Pediatr Nephrol       Date:  2016-09-01       Impact factor: 3.714

Review 6.  Hereditary kidney cancer syndromes.

Authors:  Naomi B Haas; Katherine L Nathanson
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

7.  Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

Authors:  Brian J Siroky; Hong Yin; Bradley P Dixon; Ryan J Reichert; Anna R Hellmann; Thiruvamoor Ramkumar; Zenta Tsuchihashi; Marlene Bunni; Joshua Dillon; P Darwin Bell; Julian R Sampson; John J Bissler
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

8.  Tuberous sclerosis complex-associated renal angiomyolipomas: A single center study of 17 consecutive cases.

Authors:  Hang Wang; Qilai Long; Yiwei Wang; Li Liu; Lin Zhou; Jianming Guo
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

9.  Tuberous sclerosis complex: Imaging characteristics in 11 cases and review of the literature.

Authors:  Shan Hu; Dao-Yu Hu; Wen-Zhen Zhu; Liang Wang; Zi Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

10.  Renal involvement in tuberous sclerosis complex with emphasis on cystic lesions.

Authors:  Arthur Robert; Valerie Leroy; Audrey Riquet; Lucile Gogneaux; Nathalie Boutry; Fred E Avni
Journal:  Radiol Med       Date:  2015-07-29       Impact factor: 3.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.